Log In
Print
BCIQ
Print
Print this Print this
 

Helixate FS, Helixate NexGen

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionRecombinant non-plasma derived Factor VIII
Molecular Target Factor VIII
Mechanism of ActionProcoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat and prevent bleeding in patients with hemophilia A; Treat hemophilia A
Regulatory Designation

Partner

Bayer AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today